A prospective, multicenter, randomized, controlled clinical trial comparing polatuzumab vedotin, zanubrutinib, lenalidomide, and rituximab (Pola-ZR2) versus zanubrutinib, lenalidomide, and rituximab (ZR2) in the treatment of previously untreated, elderly patients with diffuse large B-cell lymphoma (NCT06522555)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Fan Zhang, Zi-Yang Shi, Qing Shi, Yan Zhu, Wei Li Zhao, Li Wang
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108637852
Cites:
Cited by:
Related to: